82 articles by Ricky Zipp
-
Patient deaths called 'injury,' 'other' in FDA medical device database: study
July 30, 2021 -
Boston Scientific tops pre-pandemic results in Q2, expects similar trends in H2
July 27, 2021 -
FDA labels Philips sleep apnea, ventilator recall Class I, ResMed eyes advantage
July 23, 2021 -
CDRH still digging out of backlog caused by COVID-19: Shuren
July 22, 2021 -
J&J medical device sales return to pre-pandemic levels in Q2 as COVID-19 impact wanes
July 21, 2021 -
Medtech M&A expected to be robust in second half after 2021 began with a flurry
July 18, 2021 -
Dexcom wins FDA nod for real-time APIs, allowing third-party developers access to CGM data
July 16, 2021 -
CMS again passes on national pricing for long-term cardiac monitoring, dramatically reduced rates remain
July 14, 2021 -
Medtech pay to doctors plunged in 2020 as COVID-19 pummeled electives, in-person services fell
July 12, 2021 -
Hillrom ordered to complete BardyDx transaction by Delaware court
July 12, 2021 -
Dexcom CEO on the Type 2 population, the Super Bowl ad and pandemic momentum
July 6, 2021 -
Medtronic smart insulin pen improved time in target blood glucose levels: study
June 29, 2021 -
Boston Scientific spends $295M to snap up rest of cardiac ablation maker Farapulse
June 24, 2021 -
AdvaMed urges Biden to prioritize medical supplies as industries suffer shipping constraints
June 23, 2021 -
Medicare CGM eligibility widened in potential boon for Abbott, Dexcom
June 18, 2021 -
ResMed's stock climbs following Philips' sleep apnea, ventilator device recall
June 14, 2021 -
Medtronic's HeartWare HVAD ending brings questions about $1B acquisition
June 8, 2021 -
Medtronic pulls HeartWare HVAD pump from market amid recalls, patient deaths
June 3, 2021 -
Amid pricing tumult, iRhythm CEO resigns after 4 months in office
June 2, 2021 -
Medtronic HeartWare system hit with slew of Class I recalls, device reports since 2012 PMA
May 21, 2021 -
Edwards tricuspid valve replacement cut leakage for 98% of participants in early trial results
May 17, 2021 -
Diabetes tech companies continue 2020's success with Q1 growth. Investors seem unimpressed.
May 12, 2021 -
Medtronic hit with another Class I recall regarding HeartWare HVAD system
May 12, 2021 -
iRhythm again meets with Medicare rate setter after cardiac monitoring pay cut by nearly $200
May 7, 2021 -
Zimmer sees Q1 sales growth after CEO warned of down quarter
May 4, 2021